{"id":"https://openalex.org/W2084597906","doi":"https://doi.org/10.1055/s-2005-925475","title":"Thrombotic Microangiopathy in Transplantation and Malignancy","display_name":"Thrombotic Microangiopathy in Transplantation and Malignancy","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2084597906","doi":"https://doi.org/10.1055/s-2005-925475","mag":"2084597906","pmid":"https://pubmed.ncbi.nlm.nih.gov/16388420"},"language":"en","primary_location":{"id":"doi:10.1055/s-2005-925475","doi":"https://doi.org/10.1055/s-2005-925475","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2005-925475","pdf_url":null,"source":{"id":"https://openalex.org/S96726197","display_name":"Seminars in Thrombosis and Hemostasis","issn_l":"0094-6176","issn":["0094-6176","1098-9064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in Thrombosis and Hemostasis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111863376","display_name":"Lirong Qu","orcid":"https://orcid.org/0009-0008-2032-3719","observed_orcids":["https://orcid.org/0009-0008-2032-3719"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210087764","display_name":"Institute for Transfusion Medicine","ror":"https://ror.org/0036wpk65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087764"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lirong Qu","raw_affiliation_strings":["Institute for Transfusion Medicine and Department of Pathology, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania 15213, USA","Institute for Transfusion Medicine and Department of Pathology, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Transfusion Medicine and Department of Pathology, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania 15213, USA","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210087764"]},{"raw_affiliation_string":"Institute for Transfusion Medicine and Department of Pathology, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210087764"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047472906","display_name":"Joseph E. Kiss","orcid":"https://orcid.org/0000-0001-6767-1528","observed_orcids":["https://orcid.org/0000-0001-6767-1528"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph E Kiss","raw_affiliation_strings":["Associate Professor, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Associate Professor, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.537,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.82135164,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"31","issue":"06","first_page":"691","last_page":"699"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thrombotic-microangiopathy","display_name":"thrombotic microangiopathy","score":1.0},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.9259999990463257},{"id":"https://openalex.org/keywords/solid-organ-transplantation","display_name":"solid organ transplantation","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.7319999933242798},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":1.0},{"id":"https://openalex.org/keywords/calcineurin-inhibitors","display_name":"calcineurin inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/kidney-transplantation","display_name":"kidney transplantation","score":0.6299999952316284},{"id":"https://openalex.org/keywords/thrombotic-thrombocytopenic-purpura","display_name":"thrombotic thrombocytopenic purpura","score":0.9549999833106995},{"id":"https://openalex.org/keywords/therapeutic-plasma-exchange","display_name":"plasma exchange","score":0.9309999942779541},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.5440000295639038},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.4749999940395355}],"concepts":[{"id":"https://openalex.org/C2777878052","wikidata":"https://www.wikidata.org/wiki/Q3312044","display_name":"Thrombotic microangiopathy","level":3,"score":0.9067691564559937},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8387140035629272},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.7058775424957275},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.6052424907684326},{"id":"https://openalex.org/C2778585876","wikidata":"https://www.wikidata.org/wiki/Q1426491","display_name":"Thrombotic thrombocytopenic purpura","level":3,"score":0.6020830869674683},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5912761688232422},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.5560559034347534},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5477170944213867},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4644041061401367},{"id":"https://openalex.org/C128057223","wikidata":"https://www.wikidata.org/wiki/Q420566","display_name":"Calcineurin","level":3,"score":0.4348955452442169},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.4253212809562683},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.33188140392303467},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.09174147248268127}],"mesh":[{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006086","descriptor_name":"Graft vs Host Disease","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D010951","descriptor_name":"Plasma Exchange","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011697","descriptor_name":"Purpura, Thrombotic Thrombocytopenic","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D011697","descriptor_name":"Purpura, Thrombotic Thrombocytopenic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D011697","descriptor_name":"Purpura, Thrombotic Thrombocytopenic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-2005-925475","doi":"https://doi.org/10.1055/s-2005-925475","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2005-925475","pdf_url":null,"source":{"id":"https://openalex.org/S96726197","display_name":"Seminars in Thrombosis and Hemostasis","issn_l":"0094-6176","issn":["0094-6176","1098-9064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in Thrombosis and Hemostasis","raw_type":"journal-article"},{"id":"pmid:16388420","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16388420","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in thrombosis and hemostasis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3030133575","https://openalex.org/W2470638011","https://openalex.org/W4389259105","https://openalex.org/W3088084079","https://openalex.org/W2022195526","https://openalex.org/W1775316866","https://openalex.org/W1535247660","https://openalex.org/W2970395741","https://openalex.org/W2574248173","https://openalex.org/W2550307743"],"abstract_inverted_index":{"Thrombotic":[0],"microangiopathy":[1],"(TMA)":[2],"after":[3],"hematopoietic":[4],"stem-cell":[5],"transplantation":[6,10,54],"(HSCT)":[7],"or":[8,50,117,135,151],"solid-organ":[9,106],"is":[11,38,45,138,153],"a":[12],"serious":[13],"complication":[14],"that":[15],"may":[16,112,175],"be":[17,113],"associated":[18,102,114],"with":[19,103,115,122,132,172],"diverse":[20],"clinical":[21,42,59,173],"conditions.":[22],"The":[23,140],"reported":[24,100],"incidence":[25],"varies":[26],"widely,":[27],"in":[28,53,105,145,177],"part":[29],"due":[30],"to":[31],"different":[32],"diagnostic":[33,179],"criteria.":[34],"Currently,":[35],"the":[36,70,75,80,97,118,128,146,156,178],"diagnosis":[37],"based":[39],"mostly":[40],"on":[41],"features":[43,60,162,174],"and":[44,55,86,91,94,168,193,198],"often":[46],"uncertain;":[47],"many":[48],"disease":[49,78],"therapy-related":[51],"complications":[52],"malignancy":[56,119,137,152],"can":[57],"manifest":[58],"of":[61,72,82,142,148,181,190,196],"TMA.":[62],"Risk":[63],"factors":[64],"for":[65,88,130],"TMA":[66,104,111,124,133,149,182],"post":[67,183],"HSCT":[68],"include":[69],"type":[71],"conditioning":[73],"regimen,":[74],"presence":[76],"graft-versus-host":[77],"(GVHD),":[79],"use":[81],"calcineurin":[83],"inhibitors":[84],"(cyclosporine":[85],"tacrolimus)":[87],"GVHD":[89],"prophylaxis,":[90],"infection.":[92],"Cyclosporin":[93],"tacrolimus":[95],"are":[96],"most":[98],"commonly":[99],"agents":[101],"(mainly":[107],"kidney)":[108],"transplantations.":[109],"Cancer-related":[110],"chemotherapy":[116],"itself.":[120],"Compared":[121],"idiopathic":[123],"(thrombotic":[125],"thrombocytopenic":[126],"purpura),":[127],"outcome":[129],"patients":[131],"post-HSCT":[134,150],"disseminated":[136],"poor.":[139],"efficacy":[141],"plasma":[143],"exchange":[144],"treatment":[147,191],"uncertain.":[154],"In":[155],"future,":[157],"objective":[158],"criteria":[159],"integrating":[160],"laboratory":[161],"(including":[163],"tissue":[164],"pathology,":[165],"quantitative":[166],"hematology,":[167],"endothelial":[169],"cell":[170],"functionality)":[171],"assist":[176],"accuracy":[180],"HSCT,":[184],"which":[185],"would":[186],"allow":[187],"better":[188,194],"evaluation":[189],"modalities":[192],"prediction":[195],"prognosis":[197],"outcomes.":[199]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}